These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 11132951)

  • 1. Studies on anti-MRSA parenteral cephalosporins. II. Synthesis and antibacterial activity of 7beta-[2-(5-amino-1,2,4- thiadiazol-3-yl)-2(Z)-alkoxyiminoacetamido]-3-(substituted imidaz.
    Ishikawa T; Kamiyama K; Matsunaga N; Tawada H; Iizawa Y; Okonogi K; Miyake A
    J Antibiot (Tokyo); 2000 Oct; 53(10):1071-85. PubMed ID: 11132951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on anti-MRSA parenteral cephalosporins. I. Synthesis and antibacterial activity of 7beta-[2-(5-amino-1,2,4-thiadiazol-3-yl)-2(Z)- hydroxyiminoacetamido]-3-(substituted imidaz.
    Ishikawa T; Iizawa Y; Okonogi K; Miyake A
    J Antibiot (Tokyo); 2000 Oct; 53(10):1053-70. PubMed ID: 11132950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on anti-MRSA parenteral cephalosporins. III. Synthesis and antibacterial activity of 7beta-[2-(5-amino-1,2,4-thiadiazol-3-yl)-2(Z)-alkoxyiminoacetamido-3.
    Ishikawa T; Kamiyama K; Nakayama Y; Iizawa Y; Okonogi K; Miyake A
    J Antibiot (Tokyo); 2001 Mar; 54(3):257-77. PubMed ID: 11372783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on condensed-heterocyclic azolium cephalosporins. IV. Synthesis and antibacterial activity of 7 beta-[2-(5-amino-1,2,4-thiadiazol-3-yl)-2(Z)- alkoxyiminoacetamido]-3-(condensed-heterocyclic azolium)methyl cephalosporins including SCE-2787.
    Miyake A; Yoshimura Y; Yamaoka M; Nishimura T; Hashimoto N; Imada A
    J Antibiot (Tokyo); 1992 May; 45(5):709-20. PubMed ID: 1624373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S-3578, a new broad spectrum parenteral cephalosporin exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Synthesis and structure-activity relationships.
    Yoshizawa H; Itani H; Ishikura K; Irie T; Yokoo K; Kubota T; Minami K; Iwaki T; Miwa H; Nishitani Y
    J Antibiot (Tokyo); 2002 Nov; 55(11):975-92. PubMed ID: 12546419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New broad-spectrum parenteral cephalosporins exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Part 3: 7beta-[2-(5-Amino-1,2,4-thiadiazol-3-yl)-2-ethoxyiminoacetamido] cephalosporins bearing 4-[3-(aminoalkyl)-ureido]-1-pyridinium at C-3'.
    Yoshizawa H; Kubota T; Itani H; Minami K; Miwa H; Nishitani Y
    Bioorg Med Chem; 2004 Aug; 12(15):4221-31. PubMed ID: 15246098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New broad-spectrum parenteral cephalosporins exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Part 2: Synthesis and structure-activity relationships in the S-3578 series.
    Yoshizawa H; Kubota T; Itani H; Ishitobi H; Miwa H; Nishitani Y
    Bioorg Med Chem; 2004 Aug; 12(15):4211-9. PubMed ID: 15246097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on condensed-heterocyclic azolium cephalosporins. III. Synthesis and antibacterial activity of 7 beta-[2-(2-amino-5-substituted-thiazol-4-yl)-2 (Z)-alkoxyiminoacetamido]-3-(condensed-heterocyclic azolium)methyl-3-cephem-4- carboxylates.
    Nishimura T; Yoshimura Y; Miyake A
    J Antibiot (Tokyo); 1992 Apr; 45(4):485-99. PubMed ID: 1592681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on anti-MRSA parenteral cephalosporins. IV. A novel water-soluble N-phosphono type prodrug for parental administration.
    Ishikawa T; Nakayama Y; Tomimoto M; Niwa SI; Kamiyama K; Hashiguchi S; Iizawa Y; Okonogi K; Miyake A
    J Antibiot (Tokyo); 2001 Apr; 54(4):364-74. PubMed ID: 11426661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CP6679, a new injectable cephalosporin. Part 1: synthesis and structure-activity relationships.
    Masakitsushima ; Iwamatsu K; Umemura E; Kudo T; Sato Y; Shiokawa S; Takizawa H; Kano Y; Kobayashi K; Ida T; Tamura A; Atsumi K
    Bioorg Med Chem; 2000 Dec; 8(12):2781-9. PubMed ID: 11131169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CP6679, a new injectable cephalosporin with broad spectrum and potent activities against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa.
    Ida T; Tsushima M; Ishii T; Atsumi K; Tamura A
    J Infect Chemother; 2002 Jun; 8(2):138-44. PubMed ID: 12111566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo antibacterial activity of S-3578, a new broad-spectrum cephalosporin: methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa experimental infection models.
    Tsuji M; Takema M; Miwa H; Shimada J; Kuwahara S
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2507-12. PubMed ID: 12878512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro combined effects of cefozopran/teicoplanin and cefozopran/vancomycin on methicillin-resistant Staphylococcus aureus.
    Toyokawa M; Asari S; Nishi I; Horikawa M; Tsukamoto H; Sunada A; Ueda A; Iwatani Y
    J Chemother; 2003 Feb; 15(1):31-6. PubMed ID: 12678411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological properties of a series of optically active 2-oxaisocephems.
    Tsubouchi H; Ishikawa H
    Bioorg Med Chem; 1995 Feb; 3(2):143-50. PubMed ID: 7796047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on condensed-heterocyclic azolium cephalosporins. I. Synthesis and antibacterial activity of 7 beta-[2-(2-aminothiazol-4-yl)-2(Z)- alkoxyiminoacetamido]-3-(imidazo[1,2-a]pyridinium-1-yl)methyl-3- cephem-4-carboxylates.
    Nishimura T; Yoshimura Y; Yamaoka M; Kawai T; Miyake A
    J Antibiot (Tokyo); 1991 Dec; 44(12):1371-93. PubMed ID: 1778789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on 3'-quaternary ammonium cephalosporins--III. Synthesis and antibacterial activity of 3'-(3-aminopyrazolium) cephalosporins.
    Ohki H; Kawabata K; Inamoto Y; Okuda S; Kamimura T; Sakane K
    Bioorg Med Chem; 1997 Mar; 5(3):557-67. PubMed ID: 9113334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antibacterial activities of 2-oxaisocephems.
    Tsubouchi H; Tsuji K; Yasumura K; Ishikawa H
    Chem Pharm Bull (Tokyo); 1994 Oct; 42(10):2084-9. PubMed ID: 7805133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel series of parenteral cephalosporins exhibiting potent activities against Pseudomonas aeruginosa and other Gram-negative pathogens: synthesis and structure-activity relationships.
    Yamawaki K; Nomura T; Yasukata T; Uotani K; Miwa H; Takeda K; Nishitani Y
    Bioorg Med Chem; 2007 Nov; 15(21):6716-32. PubMed ID: 17723304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on condensed-heterocyclic azolium cephalosporins. V. Synthesis and antibacterial activity of 3-(condensed-triazolo-pyridinium, -pyrimidinium, and -pyridazinium)-methyl cephalosporins.
    Yoshimura Y; Tomimatsu K; Nishimura T; Miyake A; Hashimoto N
    J Antibiot (Tokyo); 1992 May; 45(5):721-34. PubMed ID: 1624374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on condensed-heterocyclic azolium cephalosporins. II. Synthesis and antibacterial activity of 7 beta-[2-(2-aminothiazol-4-yl)-2(Z)-alkoxyiminoacetamido]-3-(condensed- heterocyclic azolium)methyl-3-cephem-4-carboxylates.
    Yoshimura Y; Miyake A; Nishimura T; Kawai T; Yamaoka M
    J Antibiot (Tokyo); 1991 Dec; 44(12):1394-405. PubMed ID: 1778790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.